West Pharmaceutical Services Inc
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; sy… Read more
Market Cap & Net Worth: West Pharmaceutical Services Inc (WST)
West Pharmaceutical Services Inc (NYSE:WST) has a market capitalization of $17.24 Billion ($17.24 Billion) as of March 18, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #1128 globally and #872 in its home market, demonstrating a -3.48% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying West Pharmaceutical Services Inc's stock price $239.42 by its total outstanding shares 72021491 (72.02 Million).
West Pharmaceutical Services Inc Market Cap History: 2015 to 2026
West Pharmaceutical Services Inc's market capitalization history from 2015 to 2026. Data shows growth from $4.18 Billion to $17.24 Billion (15.39% CAGR).
Index Memberships
West Pharmaceutical Services Inc is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P 500 Index
GSPC
|
$53.17 Trillion | 0.03% | #383 of 503 |
Weight: West Pharmaceutical Services Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
West Pharmaceutical Services Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how West Pharmaceutical Services Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
6.45x
West Pharmaceutical Services Inc's market cap is 6.45 times its annual revenue
169.90x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
40.14x
West Pharmaceutical Services Inc's market cap is 40.14 times its annual earnings
862.31x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $5.93 Billion | $1.51 Billion | $143.60 Million | 3.93x | 41.33x |
| 2017 | $6.94 Billion | $1.60 Billion | $150.70 Million | 4.34x | 46.08x |
| 2018 | $6.94 Billion | $1.72 Billion | $206.90 Million | 4.04x | 33.54x |
| 2019 | $10.70 Billion | $1.84 Billion | $241.70 Million | 5.80x | 44.25x |
| 2020 | $20.22 Billion | $2.15 Billion | $346.20 Million | 9.42x | 58.40x |
| 2021 | $33.54 Billion | $2.83 Billion | $661.80 Million | 11.85x | 50.68x |
| 2022 | $16.87 Billion | $2.89 Billion | $585.90 Million | 5.85x | 28.79x |
| 2023 | $25.30 Billion | $2.95 Billion | $593.40 Million | 8.57x | 42.64x |
| 2024 | $23.59 Billion | $2.89 Billion | $492.70 Million | 8.16x | 47.88x |
| 2025 | $19.82 Billion | $3.07 Billion | $493.70 Million | 6.45x | 40.14x |
Competitor Companies of WST by Market Capitalization
Companies near West Pharmaceutical Services Inc in the global market cap rankings as of March 18, 2026.
Key companies related to West Pharmaceutical Services Inc by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #98 globally with a market cap of $170.40 Billion USD.
- EssilorLuxottica Société anonyme (PINK:ESLOF): Ranked #263 globally with a market cap of $78.22 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #362 globally with a market cap of $61.18 Billion USD ( €59.61 Billion EUR).
- Becton Dickinson and Company (NYSE:BDX): Ranked #472 globally with a market cap of $45.90 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #98 | Intuitive Surgical Inc | NASDAQ:ISRG | $170.40 Billion | $482.76 |
| #263 | EssilorLuxottica Société anonyme | PINK:ESLOF | $78.22 Billion | $265.00 |
| #362 | EssilorLuxottica S. A. | PA:EL | $61.18 Billion | €203.00 |
| #472 | Becton Dickinson and Company | NYSE:BDX | $45.90 Billion | $161.64 |
West Pharmaceutical Services Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, West Pharmaceutical Services Inc's market cap moved from $4.18 Billion to $ 17.24 Billion, with a yearly change of 15.39%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $17.24 Billion | -12.98% |
| 2025 | $19.82 Billion | -16.00% |
| 2024 | $23.59 Billion | -6.75% |
| 2023 | $25.30 Billion | +49.97% |
| 2022 | $16.87 Billion | -49.70% |
| 2021 | $33.54 Billion | +65.88% |
| 2020 | $20.22 Billion | +89.05% |
| 2019 | $10.70 Billion | +54.13% |
| 2018 | $6.94 Billion | -0.08% |
| 2017 | $6.94 Billion | +17.02% |
| 2016 | $5.93 Billion | +41.87% |
| 2015 | $4.18 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of West Pharmaceutical Services Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $17.24 Billion USD |
| MoneyControl | $17.24 Billion USD |
| MarketWatch | $17.24 Billion USD |
| marketcap.company | $17.24 Billion USD |
| Reuters | $17.24 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.